Evidence map›Paper›PMID 36839482›Full record

ReviewPathogens (Basel, Switzerland)2023

Tuberculosis-Associated Immune Reconstitution Inflammatory Syndrome-An Extempore Game of Misfiring with Defense Arsenals.

Ramachandran Vignesh, Pachamuthu Balakrishnan, Hong Yien Tan, Yean Kong Yong, Vijayakumar Velu, Marie Larsson, Esaki M Shankar

Open access · goldAbstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
7.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. RBMX2 linkseLife · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 4 countries.

Ramachandran VigneshPreclinical Department, Faculty of Medicine, Royal College of Medicine Perak, Universiti Kuala Lumpur, Ipoh 30450, Perak, Malaysia.ORCID 0000-0001-5805-9169
Pachamuthu BalakrishnanDepartment of Microbiology, Centre for Infectious Diseases, Saveetha Dental College and Hospitals, Saveetha Institute of Medical and Technical Sciences (SIMATS), Chennai 600077, Tamil Nadu, India.
Hong Yien TanSchool of Traditional Chinese Medicine, Xiamen University Malaysia, Sepang 43900, Selangor, Malaysia.
Yean Kong YongLaboratory Centre, Xiamen University Malaysia, Sepang 43900, Selangor, Malaysia.
Vijayakumar VeluDivision of Microbiology and Immunology, Yerkes National Primate Research Center, Emory University, Atlanta, GA 30322, USA.ORCID 0000-0003-4238-1924
Marie LarssonDepartment of Biomedicine and Clinical Sciences, Linköping University, 58185 Linköping, Östergotland, Sweden.ORCID 0000-0002-4524-0177
Esaki M ShankarInfection and Inflammation, Department of Biotechnology, Central University of Tamil Nadu, Thiruvarur 610005, Tamil Nadu, India.ORCID 0000-0002-7866-9818
Xiamen University Malaysia · MYCentral University of Tamil Nadu · INEmory University · USLinköping University · SESaveetha University · INUniversity of Kuala Lumpur · MY

Funding

Emory/Georgia TB Research Advancement Center (TRAC)P30AI168386 · NIAID · EMORY UNIVERSITY · PI Jeffrey M Collins · 2022 to 2026
$5.8M
NIAID NIH HHS P30 AI168386
6 · The paper itself

Abstract

The lethal combination involving TB and HIV, known as "syndemic" diseases, synergistically act upon one another to magnify the disease burden. Individuals on anti-retroviral therapy (ART) are at risk of developing TB-associated immune reconstitution inflammatory syndrome (TB-IRIS). The underlying inflammatory complication includes the rapid restoration of immune responses following ART, eventually leading to exaggerated inflammatory responses to MTB antigens. TB-IRIS continues to be a cause of morbidity and mortality among HIV/TB coinfected patients initiating ART, and although a significant quantum of knowledge has been acquired on the pathogenesis of IRIS, the underlying pathomechanisms and identification of a sensitive and specific diagnostic marker still remain a grey area of investigation. Here, we reviewed the latest research developments into IRIS immunopathogenesis, and outlined the modalities to prevent and manage strategies for better clinical and diagnostic outcomes for IRIS.

Indexed as

ARTbiomarkersHIVinflammationIRIStuberculosis

Identifiers

PMID36839482
PMCPMC9964757
OpenAlexW4318474576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.